EP1699512B1 — A fluid dispensing device
Assigned to Glaxo Group Ltd · Expires 2012-06-20 · 14y expired
What this patent protects
A fluid dispensing device (5, 105, 205, 305, 405, 505) for dispensing a fluid form medicament formulation having a viscosity of from 10 to 2000 mPa.s. is disclosed and comprises a housing (9, 109, 209, 309, 409, 509) and a fluid discharge device (8, 108, 208, 308, 408, 508) arran…
USPTO Abstract
A fluid dispensing device (5, 105, 205, 305, 405, 505) for dispensing a fluid form medicament formulation having a viscosity of from 10 to 2000 mPa.s. is disclosed and comprises a housing (9, 109, 209, 309, 409, 509) and a fluid discharge device (8, 108, 208, 308, 408, 508) arranged to be actuated by one or more levers (20, 21; 120, 121; 170; 220, 221; 320, 321; 420, 421; 520) to cause actuation of a pump forming part of the fluid discharge device. A pre-load means (28; 27, 28; 39,40; 41, 42, 44; 144, 47a, 47b; 150, 152, 153; 224, 227; 342; 424x, 446; 425a; 427, 428; 560, 561) is used to prevent actuation of the pump until a pre-determined force is applied to each lever of sufficient magnitude to guarantee the production of a well developed efficient spray from the fluid dispensing device.
Drugs covered by this patent
- Arnuity Ellipta (FLUTICASONE FUROATE) · Haleon Us Holdings
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.